Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orland

Showing results (391-400 of 444) with videos related to

Pageof 45
Sort By:
Breast Cancer Research and Treatment|July 24, 2010
International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutationAna Peixoto, Catarina Santos, Manuela Pinheiro, et al.
JCO Precision Oncology|September 14, 2019
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSarah M Nielsen, Diana M Eccles, Iris L Romero, et al.
Circulation. Genomic and Precision Medicine|May 28, 2024
Meta-Analysis of Genome-Wide Association Studies Reveals Genetic Mechanisms of Supraventricular ArrhythmiasLu-Chen Weng, Shaan Khurshid, Amelia Weber Hall, et al.
Nature Genetics|January 2, 2025
The impact of common and rare genetic variants on bradyarrhythmia developmentLu-Chen Weng, Joel T Rämö, Sean J Jurgens, et al.
Journal of Medical Genetics|May 14, 2026
Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languagesArcangela De Nicolo, Diana M Eccles, Kirsimari Aaltonen, et al.
Human Molecular Genetics|July 2, 2015
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factorPaolo Peterlongo, Irene Catucci, Mara Colombo, et al.
Breast Cancer Research : BCR|November 13, 2016
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 womenTimothy R Rebbeck, Tara M Friebel, Nandita Mitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Cancer Risks Associated With Germline <i>PALB2</i> Pathogenic Variants: An International Study of 524 FamiliesXin Yang, Goska Leslie, Alicja Doroszuk, et al.
JAMA Oncology|July 3, 2020
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Valentina Silvestri, Goska Leslie, Daniel R Barnes, et al.
British Journal of Cancer|June 20, 2019
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriersFrank Qian, Matti A Rookus, Goska Leslie, et al.
Pageof 45

Showing results (391-400 of 444) with videos related to

Sort By:
Pageof 45
Breast Cancer Research and Treatment|July 24, 2010
International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutationAna Peixoto, Catarina Santos, Manuela Pinheiro, et al.
JCO Precision Oncology|September 14, 2019
Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSarah M Nielsen, Diana M Eccles, Iris L Romero, et al.
Circulation. Genomic and Precision Medicine|May 28, 2024
Meta-Analysis of Genome-Wide Association Studies Reveals Genetic Mechanisms of Supraventricular ArrhythmiasLu-Chen Weng, Shaan Khurshid, Amelia Weber Hall, et al.
Nature Genetics|January 2, 2025
The impact of common and rare genetic variants on bradyarrhythmia developmentLu-Chen Weng, Joel T Rämö, Sean J Jurgens, et al.
Journal of Medical Genetics|May 14, 2026
Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languagesArcangela De Nicolo, Diana M Eccles, Kirsimari Aaltonen, et al.
Human Molecular Genetics|July 2, 2015
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factorPaolo Peterlongo, Irene Catucci, Mara Colombo, et al.
Breast Cancer Research : BCR|November 13, 2016
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 womenTimothy R Rebbeck, Tara M Friebel, Nandita Mitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Cancer Risks Associated With Germline <i>PALB2</i> Pathogenic Variants: An International Study of 524 FamiliesXin Yang, Goska Leslie, Alicja Doroszuk, et al.
JAMA Oncology|July 3, 2020
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Valentina Silvestri, Goska Leslie, Daniel R Barnes, et al.
British Journal of Cancer|June 20, 2019
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriersFrank Qian, Matti A Rookus, Goska Leslie, et al.
Pageof 45